Skip to main content

What DaVita's Quarter ended Sep 30, 2026 10-Q says: 3 signals

DaVita filed its latest 10-Q with the SEC on Oct 29, 2026. It discusses compliance burden, cybersecurity incident and product launch.

Public (DVA)Hospitals and Health Care10,000+ employeesdavita.comLinkedIn

Get DaVita's live signals in Claude or ChatGPT, or by API

AskWhat changed at DaVita this week? Use Autobound signals for davita.com.
Filed
Oct 29, 2026
Period
Quarter ended Sep 30, 2026
Filings
3
Signals
6

Source: Autobound Signal API · 31 signals tracked for DaVita · updated

10-Q · latest 6

What DaVita's 10-Q filings say

  1. 10-Q · Quarter ended Sep 30, 2026

    Filed · 3 signals

    SEC EDGAR
  2. 10-Q · Quarter ended Jun 30, 2026

    Filed · 1 signal

    SEC EDGAR
  3. 10-Q · Quarter ended Mar 31, 2026

    Filed · 2 signals

    SEC EDGAR

Earnings calls

DaVita earnings headlines

From earnings call transcripts (Signal API type earnings-transcripts).

Earnings call headlines
Call dateWhat the company said
Expanded Humana partnership adds 10,000 CKD patients upstreamDaVita entered into an expanded partnership with Humana to bring upstream kidney care management to roughly 10,000 chronic kidney disease patients. The partnership directly expands medical spend under management for the outperforming Integrated Kidney Care division.
Nationwide rollout of expanded HD dialyzers starting NovemberDaVita is launching a national rollout of expanded HD dialyzers across its network in November after pilots across 150 centers and 10,000 patients. The new technology is compatible with existing dialysis machines and is targeted to reach approximately 75% of clinically eligible patients, aiming for long-term volume growth by 2029.
Modernizing tech platform with over $1B multi-year investmentDaVita has deployed over $1B in recent years to modernize internal platforms across revenue operations, clinical care management, and labor productivity. While IT spending grew over 20% year-over-year in Q3 creating near-term cost drag, management projects future technology investment growth will decelerate.
CMS ESRD final rule incorporates quarterly TDAPA adjustmentsCMS released the final ESRD rule granting an initial 3.5% rate increase for large dialysis organizations, but add-on TDAPA payments will be recalculated downward quarterly after Q1. The net impact for DaVita is estimated between 1.5% and 2.0% for 2027, where each 1% change equates to $30M in annual revenue.
Patient care cost per treatment rose 2.4% year-over-yearOperating costs per treatment increased 2.4% in Q3 driven by general labor expenses, medical supply costs, and professional liability expenses. These cost increases were only partially offset by lower phosphate binder costs.
ACA exchange shifts driving $40M headwind to commercial mixDaVita is managing an estimated $40M commercial mix headwind in 2026 tied to the expiration of enhanced premium tax credits on ACA exchanges. Commercial revenue declines remain a continuous headwind against overall revenue per treatment.

Signal API · MCP

Track DaVita with the Signal API

One POST /v1/companies/enrich call with davita.com returns DaVita 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"davita.com","signal_types":["sec-10q"],"limit":20}'

Bulk data

Need this signal for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real 10-Q Filings records, as a CSV.

Talk to sales

Same industry

Questions about DaVita 10-Q

When did DaVita file its latest 10-Q?
DaVita filed its latest 10-Q (Quarter ended Sep 30, 2026) on Oct 29, 2026. The one before it was filed on Aug 4, 2026.
What did DaVita disclose in its latest 10-Q?
From the filing dated Oct 29, 2026: DaVita to Roll Out Expanded Hemodialysis Therapy to Eligible Patients in November
What did DaVita say on its recent earnings calls?
Q3 FY2026: Expanded Humana partnership adds 10,000 CKD patients upstream (dated Oct 29, 2026).
Where can I read DaVita's 10-Q filing?
The full filing is on SEC EDGAR: https://www.sec.gov/Archives/edgar/data/927066/000092706626000134/dva-20260930.htm. This page summarizes what the filing says and links to it.

Page updated , the date of the newest row on this page.

Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.

Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.

Data as of .

How this data is built →Get it from the Signal API →